Tag Archive
MagForce Nanotechnologies AG appoints Dr. Peter Heinrich as Chief Executive Officer (Business Wire via Yahoo! Finance)
BERLIN—-MagForce Nanotechnologies AG has announced the appointment of Dr. Peter Heinrich, until now the deputy chairman of its supervisory board, as the company’s new chief executive officer effective January 1, 2010. (read the story…) Related items Professor Wolfgang Heckl Appointed to Supervisory Board Of MagForce Nanotechnologies AG (Business Wire via Yahoo! Finance) MagForce Nanotechnologies AG Applies for European... »
MagForce Nanotechnologies AG Applies for European Regulatory Approval of Its Nano-Cancer® Therapy (Business Wire via Yahoo! Finance)
BERLIN—-MagForce Nanotechnologies AG has submitted the product file for NanoTherm® to Medcert GmbH, the medical certification and testing company which serves as Notified Body for the certification of medical products. (read the story…) Related items MagForce Nanotechnologies AG Applies For European Regulatory Approval Of Its Nano-Cancer(R) Therapy (Medical News Today) MagForce Nanotechnologies initiates conformity assessment procedure for its... »
MagForce Nanotechnologies AG reaches primary study endpoint in pivotal glioblastoma study (Business Wire via Yahoo! Finance)
BERLIN—-MagForce Nanotechnologies AG has successfully completed its single-arm clinical trial on the efficacy of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma. (read the story…) Related items MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients (News-Medical-Net) MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study (Business Wire via Yahoo! Finance) Chemist Monitors Nanotechnology’s Environmental Impact... »
Nanostart Majority-Owned MagForce Announces Successful Completion of Final Clinical Trials For Nano-Cancer® Therapy (Business Wire via Yahoo! Finance)
FRANKFURT & BERLIN—-MagForce Nanotechnologies AG, the Berlin-based medical technology company majority owned by Nanostart AG, today announced the successful completion of final trials demonstrating the efficacy of its Nano-Cancer® therapy in patients with recurrent glioblastoma, a frequent form of brain tumor which is highly malignant. (read the story…) Related items MagForce Nanotechnologies announces successful completion of its... »
MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study (Business Wire via Yahoo! Finance)
BERLIN—-MagForce Nanotechnologies AG has successfully completed patient recruitment for its study on recurrent glioblastoma, which is of critical importance for demonstrating the efficacy of its proprietary Nano-Cancer® therapy. (read the story…) Related items MagForce Nanotechnologies Completes Patient Recruitment For Pivotal Glioblastoma Study (Medical News Today) Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy... »
